Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DPP4 promotes an immunoenhancing tumor microenvironment through exhausted CD8+ T cells with activating IL13-IL13RA2 axis in papillary thyroid cancer. | Int Immunopharmacol | 2025 | 39662266 | PubTator, text mining | PubMed |
| Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. | Cell Stem Cell | 2025 | 39657679 | PubTator, text mining | PubMed |
| Leptin augments IL-13-induced airway eotaxins and submucosal eosinophilia in obesity-associated asthma. | J Allergy Clin Immunol | 2025 | 39581293 | PubTator, text mining | PubMed |
| Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway. | J Adv Res | 2025 | 38432393 | PubTator, text mining | PubMed |
| Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells. | J Immunother Cancer | 2024 | 39622583 | PubTator, text mining | PubMed |
| IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients. | Pharmaceuticals (Basel) | 2024 | 39598436 | PubTator, text mining | PubMed |
| Gut-derived IL-13 contributes to growth via promoting hepatic IGF-1 production. | Microbiome | 2024 | 39580435 | PubTator, text mining | PubMed |
| Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma. | Discov Oncol | 2024 | 39472405 | PubTator, text mining | PubMed |
| Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme. | Cells | 2024 | 39329751 | PubTator, text mining | PubMed |
| Construction of an artificial neural network diagnostic model and investigation of immune cell infiltration characteristics for idiopathic pulmonary fibrosis. | BMC Pulm Med | 2024 | 39289672 | PubTator, text mining | PubMed |
| IL13RA2 promotes progression of infantile haemangioma by activating glycolysis and the Wnt/β-catenin signaling pathway. | Oncol Res | 2024 | 39220137 | PubTator, text mining | PubMed |
| Interleukin Profiling in Atopic Dermatitis and Chronic Nodular Prurigo. | Int J Mol Sci | 2024 | 39126011 | PubTator, text mining | PubMed |
| Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma. | Mol Ther | 2024 | 39086131 | PubTator, text mining | PubMed |
| MicroRNA-155-5p Differentially Regulates IL-13Rα1 and IL-13Rα2 Expression and Signaling Driving Abnormal Lung Epithelial Cell Phenotype in Severe Asthma. | Am J Respir Cell Mol Biol | 2024 | 39051933 | PubTator, text mining | PubMed |
| Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial. | JAMA Dermatol | 2024 | 39018038 | PubTator, text mining | PubMed |
| CAR-T Cells Therapy in Glioblastoma: A Systematic Review on Molecular Targets and Treatment Strategies. | Int J Mol Sci | 2024 | 39000281 | PubTator, text mining | PubMed |
| IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma. | Neuro Oncol | 2024 | 38982561 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. | J Transl Med | 2024 | 38937754 | PubTator, text mining | PubMed |
| GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy. | Mol Ther | 2024 | 38720457 | PubTator, text mining | PubMed |
| IL-13 protects from Clostridioides difficile colitis. | Anaerobe | 2024 | 38701912 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=8